Oct 20 (Reuters) - Specialty chemicals company Platform Specialty Products Corp said it will buy rival Arysta LifeScience Ltd from a company backed by private equity firm Permira for about $3.51 billion.
The company said it expects the deal to immediately add to adjusted earnings per share.
The deal is expected to be “highly complementary” to Platform’s crop protection businesses.
Arysta is a global provider of agrochemical and biological products. (Reporting By Shubhankar Chakravorty in Bangalore; Editing by Don Sebastian)